© 2020 MJH Life Sciences and Neurology Live. All rights reserved.
© 2020 MJH Life Sciences™ and Neurology Live. All rights reserved.
October 29, 2020
The SPI2 study did not replicate the improvements observed in prior study, instead suggesting that biotin (MD1003; MedDay Pharmaceuticals) is ineffective in patients with progressive MS.
Experts in multiple sclerosis review top data presented at the 8th joint ACTRIMS-ECTRIMS meeting.
October 28, 2020
The authors noted that research is still needed to establish standards for cell mobilization and immune-conditioning regimens.
October 26, 2020
Here's what is coming soon to NeurologyLive.
October 23, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 23, 2020.
October 21, 2020
On the heels of successful long-term data, evobrutinib seeks to maintain its high efficacy in 2 pivotal phase 3 clinical trials.